凝固検査市場：製品タイプ別、検査タイプ別、エンドユーザー別-2025-2030年の世界予測

凝固検査市場は、2023年に46億2,000万米ドルと評価され、2024年には50億7,000万米ドルに達すると予測され、CAGR 9.92％で成長し、2030年には89億6,000万米ドルになると予測されています。

凝固検査は、血液凝固能力を評価し、凝固障害を特定し、血友病、血栓症、抗凝固療法などの状態をモニタリングするために使用されるさまざまな医療評価を指します。出血や血栓のリスクを細かく管理する必要がある手術や治療では極めて重要であり、ヘルスケア施設、臨床検査室、病院の診断部門で重要な役割を果たしています。高齢化人口の増加と心血管障害の有病率の上昇が、正確で効率的な凝固検査に対する需要を促進しています。ヘルスケア診断に対する意識の高まりと積極的な患者ケアアプローチが市場促進要因となっています。さらに、ポイントオブケア検査や自動凝固分析装置のような技術の進歩は、検査の精度と効率を高めることで大きな成長機会をもたらしています。とはいえ、先進的な検査機器に関連する高額な費用や、未発達地域におけるアクセスの制限といった課題は、市場の拡大を阻害する可能性があります。医療機器に対する厳しい規制要件は、新規参入企業の市場参入をさらに複雑にしています。個別化医療、人工知能の統合、ウェアラブル凝固モニタリング機器に焦点を当てた技術革新は、この分野における画期的な機能強化への道を開く可能性があります。さらに、未開拓市場の開拓やデジタルヘルスプラットフォームとの連携により、より広範な導入が促進される可能性があります。凝固診断をより広範な医療調査システムと統合し、新規バイオマーカーを探索するための継続的な研究は、個別化ヘルスケアのソリューション向上につながる可能性があります。市場は主要企業が研究開発に多額の投資を行っており競合環境にあるが、こうした環境は高度な臨床介入につながるイノベーションも刺激します。まとめると、凝固検査市場は、特にコストとアクセスに関する制約に直面する一方で、特に世界ヘルスケアとの連携や診断精度の進歩を通じて、技術革新と市場拡大の機会も数多く提供しています。

市場力学：急速に進化する凝固検査市場の主要市場インサイトを公開

凝固検査市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができるとともに、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 世界の凝固障害の有病率の増加
  • 生命を脅かす血栓に対する認識を促進する政府のキャンペーン
• 市場抑制要因
  • 凝固検査の償還不足
• 市場機会
  • 凝固検査技術の進歩
  • 在宅医療向け凝固検査の登場
• 市場の課題
  • 凝固検査の技術的限界と不正確さ

ポーターのファイブフォース凝固検査市場をナビゲートする戦略ツール

ポーターのファイブフォースフレームワークは、凝固検査市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することで、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：凝固検査市場における外部からの影響の把握

外部マクロ環境要因は、凝固検査市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析凝固検査市場における競合情勢の把握

凝固検査市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス凝固検査市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、凝固検査市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨凝固検査市場における成功への道筋を描く

凝固検査市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を見直すことで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 世界中で凝固障害の罹患率が増加
    • 命を脅かす血栓に関する意識を高める政府のキャンペーン
  • 抑制要因
    • 凝固検査の払い戻しが不足しています
  • 機会
    • 凝固検査テクノロジーの進歩
    • 在宅ケアのための凝固検査の出現
  • 課題
    • 凝固検査の技術的な制限と不正確さ
• 市場セグメンテーション分析
  • 製品：凝固検査における効率性と拡張性を実現するための自動化機器の導入増加
  • エンドユーザー：遠隔患者モニタリングをサポートする家庭用凝固検査キットの採用が増加
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 凝固検査市場：製品別

• 消耗品
• 機器

第7章 凝固検査市場テストタイプ別

• 活性化部分トロンボプラスチン時間
• プロトロンビン時間
• トロンビン時間

第8章 凝固検査市場：エンドユーザー別

• 臨床検査室
• 家庭での検査
• 病院

第9章 南北アメリカの凝固検査市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の凝固検査市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの凝固検査市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
  • ロシュ社、高まる患者ニーズに応えるため、3つの新しい因子Xa阻害剤凝固検査を発売
  • HORIBA UK、IBMS会議で新型全自動血液凝固分析装置を発表2023
  • ダイアグノスティカ・スタゴ、凝固分析装置でFDA 510（k）認可を取得
• 戦略分析と提言

企業一覧

• A&T Corporation
• Abbott Laboratories
• Advin Health Care
• Becton, Dickinson and Company
• Beijing Succeeder Technology Inc.
• Bio Group Medical System SRL
• Bio-Rad Laboratories, Inc.
• Coagulation Sciences LLC
• Danaher Corporation
• Drucker Diagnostics, LLC
• F. Hoffmann-La Roche Ltd
• Genrui Biotech Inc.
• Helena Laboratories Corporation
• HORIBA, Ltd.
• Maccura Biotechnology Co., Ltd.
• Medtronic PLC
• Mindray Bio-Medical Electronics Co., Ltd.
• Sekisui Chemical Co., Ltd.
• Shenzhen Micropoint Biotechnologies Co., Ltd.
• Siemens Healthineers AG
• Stago Group
• Sysmex Corporation
• Thermo Fisher Scientific Inc.
• Trivitron Healthcare
• Tulip Diagnostics（P）Ltd

LIST OF FIGURES

• FIGURE 1. COAGULATION TESTING MARKET RESEARCH PROCESS
• FIGURE 2. COAGULATION TESTING MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL COAGULATION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 13. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 15. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 17. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. COAGULATION TESTING MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 21. COAGULATION TESTING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. COAGULATION TESTING MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL COAGULATION TESTING MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL COAGULATION TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. COAGULATION TESTING MARKET DYNAMICS
• TABLE 7. GLOBAL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL COAGULATION TESTING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL COAGULATION TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL COAGULATION TESTING MARKET SIZE, BY ACTIVATED PARTIAL THROMBOPLASTIN TIME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL COAGULATION TESTING MARKET SIZE, BY PROTHROMBIN TIME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL COAGULATION TESTING MARKET SIZE, BY THROMBIN TIME, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL COAGULATION TESTING MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOME TESTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL COAGULATION TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. AMERICAS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 19. AMERICAS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 20. AMERICAS COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 21. AMERICAS COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 22. ARGENTINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 23. ARGENTINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 24. ARGENTINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 25. BRAZIL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 26. BRAZIL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 27. BRAZIL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. CANADA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 29. CANADA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 30. CANADA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 31. MEXICO COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. MEXICO COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 33. MEXICO COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 34. UNITED STATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 35. UNITED STATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 36. UNITED STATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. UNITED STATES COAGULATION TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 38. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 39. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 40. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. ASIA-PACIFIC COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 42. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 43. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 44. AUSTRALIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. CHINA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. CHINA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 47. CHINA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. INDIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 49. INDIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 50. INDIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. INDONESIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 52. INDONESIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 53. INDONESIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. JAPAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 55. JAPAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 56. JAPAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 57. MALAYSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. MALAYSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 59. MALAYSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 60. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 61. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 62. PHILIPPINES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. SINGAPORE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. SINGAPORE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 65. SINGAPORE COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 67. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 68. SOUTH KOREA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. TAIWAN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. TAIWAN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 71. TAIWAN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 72. THAILAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 73. THAILAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 74. THAILAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. VIETNAM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. VIETNAM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 77. VIETNAM COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 79. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 80. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. EUROPE, MIDDLE EAST & AFRICA COAGULATION TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 82. DENMARK COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 83. DENMARK COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 84. DENMARK COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. EGYPT COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. EGYPT COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 87. EGYPT COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 88. FINLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 89. FINLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 90. FINLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. FRANCE COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. FRANCE COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 93. FRANCE COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. GERMANY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 95. GERMANY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 96. GERMANY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. ISRAEL COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. ISRAEL COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 99. ISRAEL COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 100. ITALY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 101. ITALY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 102. ITALY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 105. NETHERLANDS COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. NIGERIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 107. NIGERIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 108. NIGERIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. NORWAY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 110. NORWAY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 111. NORWAY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. POLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. POLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 114. POLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. QATAR COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 116. QATAR COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 117. QATAR COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. RUSSIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. RUSSIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 120. RUSSIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 121. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 122. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 123. SAUDI ARABIA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH AFRICA COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. SPAIN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 128. SPAIN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 129. SPAIN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. SWEDEN COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. SWEDEN COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 132. SWEDEN COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 133. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 134. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 135. SWITZERLAND COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. TURKEY COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. TURKEY COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 138. TURKEY COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 140. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 141. UNITED ARAB EMIRATES COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
• TABLE 144. UNITED KINGDOM COAGULATION TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 145. COAGULATION TESTING MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 146. COAGULATION TESTING MARKET, FPNV POSITIONING MATRIX, 2023

The Coagulation Testing Market was valued at USD 4.62 billion in 2023, expected to reach USD 5.07 billion in 2024, and is projected to grow at a CAGR of 9.92%, to USD 8.96 billion by 2030.

Coagulation testing refers to a variety of medical assessments used to evaluate the blood's ability to clot, identifying clotting disorders and monitoring conditions like hemophilia, thrombosis, and anticoagulant therapy. It's crucial in surgeries and treatments requiring fine management of bleeding and clot risk, thus playing a significant role in diagnostics sectors of healthcare facilities, clinical laboratories, and hospitals. The growing aging population and rising prevalence of cardiovascular disorders have propelled demand for precise and efficient coagulation tests. Increasing awareness about healthcare diagnostics and proactive patient care approaches are primary market drivers. Additionally, technological advancements like point-of-care testing and automated coagulation analyzers present significant growth opportunities by enhancing test accuracy and efficiency. Nevertheless, challenges such as high costs associated with advanced testing equipment and limited access in underdeveloped regions may impede market expansion. The stringent regulatory requirements for medical devices further complicate market entry for new players. Innovations focusing on personalized medicine, integration of artificial intelligence, and wearable coagulation monitoring devices could pave the way for breakthrough enhancements in this field. Additionally, exploring untapped markets and collaborations with digital health platforms can facilitate wider adoption. Continuous research on integrating coagulation diagnostics with broader medical surveillance systems and exploring novel biomarkers can potentially lead to improved personalized healthcare solutions. Although the market is competitive with key players investing heavily in R&D, this environment also stimulates innovation leading to advanced clinical interventions. In summary, while the coagulation testing market faces limitations, especially concerning cost and access, it also offers numerous opportunities for technological innovation and market expansion, particularly through global healthcare collaborations and advances in diagnostic accuracy.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Coagulation Testing Market

The Coagulation Testing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of coagulation disorders worldwide
  • Government campaigns promoting awareness of life-threatening blood clots
• Market Restraints
  • Lack of reimbursements for coagulation testing
• Market Opportunities
  • Advancements in coagulation testing technologies
  • Emergence of coagulation testing for homecare
• Market Challenges
  • Technical limitations and inaccuracies of coagulation testing

Porter's Five Forces: A Strategic Tool for Navigating the Coagulation Testing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Coagulation Testing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Coagulation Testing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Coagulation Testing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Coagulation Testing Market

A detailed market share analysis in the Coagulation Testing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Coagulation Testing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Coagulation Testing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Coagulation Testing Market

A strategic analysis of the Coagulation Testing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Coagulation Testing Market, highlighting leading vendors and their innovative profiles. These include A&T Corporation, Abbott Laboratories, Advin Health Care, Becton, Dickinson and Company, Beijing Succeeder Technology Inc., Bio Group Medical System SRL, Bio-Rad Laboratories, Inc., Coagulation Sciences LLC, Danaher Corporation, Drucker Diagnostics, LLC, F. Hoffmann-La Roche Ltd, Genrui Biotech Inc., Helena Laboratories Corporation, HORIBA, Ltd., Maccura Biotechnology Co., Ltd., Medtronic PLC, Mindray Bio-Medical Electronics Co., Ltd., Sekisui Chemical Co., Ltd., Shenzhen Micropoint Biotechnologies Co., Ltd., Siemens Healthineers AG, Stago Group, Sysmex Corporation, Thermo Fisher Scientific Inc., Trivitron Healthcare, and Tulip Diagnostics (P) Ltd.

Market Segmentation & Coverage

This research report categorizes the Coagulation Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product, market is studied across Consumables and Instruments.
• Based on Test Type, market is studied across Activated Partial Thromboplastin Time, Prothrombin Time, and Thrombin Time.
• Based on End-User, market is studied across Clinical Laboratories, Home Testing, and Hospitals.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of coagulation disorders worldwide
    • 5.1.1.2. Government campaigns promoting awareness of life-threatening blood clots
  • 5.1.2. Restraints
    • 5.1.2.1. Lack of reimbursements for coagulation testing
  • 5.1.3. Opportunities
    • 5.1.3.1. Advancements in coagulation testing technologies
    • 5.1.3.2. Emergence of coagulation testing for homecare
  • 5.1.4. Challenges
    • 5.1.4.1. Technical limitations and inaccuracies of coagulation testing
• 5.2. Market Segmentation Analysis
  • 5.2.1. Product: Rising deployment of automated instruments to achieve efficiency and scalability in coagulation testing
  • 5.2.2. End-User: Growing adoption of home coagulation testing kits to support remote patient monitoring
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Coagulation Testing Market, by Product

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Instruments

7. Coagulation Testing Market, by Test Type

• 7.1. Introduction
• 7.2. Activated Partial Thromboplastin Time
• 7.3. Prothrombin Time
• 7.4. Thrombin Time

8. Coagulation Testing Market, by End-User

• 8.1. Introduction
• 8.2. Clinical Laboratories
• 8.3. Home Testing
• 8.4. Hospitals

9. Americas Coagulation Testing Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Coagulation Testing Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Coagulation Testing Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. Roche Launches Three New Factor Xa Inhibitor Coagulation Tests to Meet Growing Patient Need
  • 12.3.2. HORIBA UK to Introduce New Fully Automated Haemostasis Analysers at IBMS Congress 2023
  • 12.3.3. Diagnostica Stago Nabs FDA 510(k) Clearance for Coagulation Analyzers
• 12.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. A&T Corporation
• 2. Abbott Laboratories
• 3. Advin Health Care
• 4. Becton, Dickinson and Company
• 5. Beijing Succeeder Technology Inc.
• 6. Bio Group Medical System SRL
• 7. Bio-Rad Laboratories, Inc.
• 8. Coagulation Sciences LLC
• 9. Danaher Corporation
• 10. Drucker Diagnostics, LLC
• 11. F. Hoffmann-La Roche Ltd
• 12. Genrui Biotech Inc.
• 13. Helena Laboratories Corporation
• 14. HORIBA, Ltd.
• 15. Maccura Biotechnology Co., Ltd.
• 16. Medtronic PLC
• 17. Mindray Bio-Medical Electronics Co., Ltd.
• 18. Sekisui Chemical Co., Ltd.
• 19. Shenzhen Micropoint Biotechnologies Co., Ltd.
• 20. Siemens Healthineers AG
• 21. Stago Group
• 22. Sysmex Corporation
• 23. Thermo Fisher Scientific Inc.
• 24. Trivitron Healthcare
• 25. Tulip Diagnostics (P) Ltd